Summary
Overview
Work History
Education
Skills
Languages
Personal Information
Work Availability
Websites
Timeline
6a
Mohammed Jobran

Mohammed Jobran

Regulatory Affairs Consultant, SFDA.
Riyadh

Summary

20 years of regulatory experience working for the SFDA and the Pharmaceutical industry. Successfully managed mega regulatory projects such as multinational mergers & acquisitions, the establishment of new pharma and medical device manufacturers, Tech Transfers/localisation, technical file development (eCTD, MDD/MDR TFA), in/out-licensing of portfolios, and others. Unique access abilities to the SFDA, MOH, MOHAP, and other GCC authorities. Managed joint projects with top pharma and MedTech companies such as: Pharma: Novartis, GSK, Astra Zeneca, MSD, Abbot, Amgen, and more. MedTech: PDI, SECA, SNIBE, ZOLL, Essilor, Quanta Systems, and more. Author and creator of new due diligence and gap analysis methods for products and entities. Advise with an innovative and visionary opinion in regulatory strategies (time, cost, & efficiency). Experienced with a wide range of RA projects and submission types as a firsthand implementor. High knowledge of regulations, RA intel, and industry dynamics. Excellent communication skills with global business offices and local commercial partners.

Overview

20
20
years of professional experience

Work History

Principal Consultant, Regulatory Affairs. Founder

PharmaKnowl Consulting
Riyadh
12.2019 - Current
  • 20 years of regulatory experience working for the SFDA and the Pharmaceutical industry.
  • Successfully managed mega regulatory projects such as multinational mergers & acquisitions, the establishment of new pharma and medical device manufacturers, Tech Transfers/localisation, technical file development (eCTD, MDD/MDR TFA), in/out-licensing of portfolios, and others.
  • Unique access abilities to the SFDA, MOH, MOHAP, and other GCC authorities.
  • Managed joint projects with top pharma and MedTech companies such as: Pharma: Novartis, GSK, Astra Zeneca, MSD, Abbot, Amgen, and more. MedTech: PDI, SECA, SNIBE, ZOLL, Essilor, Quanta Systems, and more.
  • Author and creator of new due diligence and gap analysis methods for products and entities.
  • Advise with an innovative and visionary opinion in regulatory strategies (time, cost, & efficiency).
  • Experienced with a wide range of RA projects and submission types as a firsthand implementor.
  • High knowledge of regulations, RA intel, and industry dynamics.
  • Excellent communication skills with global business offices and local commercial partners.
  • End-to-end regulatory services from product development to market launch.
  • New entity legal setup and new market entry projects.
  • Development of RA strategic plans with hands-on implementation.
  • Drug registrations & life cycle management.
  • Regulatory intelligence with valuable insights and interpretations.
  • Cross-functional support (quality, commercial, medical, marketing, Supply Chain, and others).
  • PV services: Outsourcing and development of Saudi PV system (PSSF), QPPV, & literature review.

Scientific Office and Regulatory Affairs Manager

Aspen Pharmacare
12.2013 - 12.2019
  • Managed multiple MA transfer projects of +70 drugs in Saudi under 5 global acquisitions with a high level of communication and collaboration with local and international partners.
  • Achieved an outstanding number of successful drug price increases with a total of 9 drug increases in SFDA and 5 central price increases at the unified GCC pricing council. That included planning, analysis, submission, and lengthy authority negotiations.
  • Managed successfully to challenge and influence the authority into cancelling a decision to reformulate the company’s best-selling drug.
  • Involved in business development projects related to regional acquisitions and licensing projects.
  • Crisis management of a couple of withdrawals and other drastic regulator decisions.
  • Negotiated and secured an exceptional approval to reroute a 2M EUR worth of goods.
  • Resolved many commercial challenges with the company’s local distributors.
  • Implemented the serialization (Track & Trace) project.
  • Built and implemented a local Pharmacovigilance system (Saudi PV sub-system file).
  • Recruitment, management, and mentoring of regulatory and PV teams.

Pharmacovigilance Manager

Aspen Pharmacare
01.2016 - 12.2019
  • Registered several pharmaceutical products, including oncology, biosimilar, and generics.
  • Several GMP site approvals in the EU, Chile, and South Africa. Accompanying SFDA inspectors.
  • Experienced with several manufacturing site transfers in the EU and locally.
  • Registered a new EU MAH office in Saudi.
  • Experienced in revision and approval of safety data (SPC, PIL, CCDS).
  • Secured a high number of exceptional approvals, import permits, and waivers.
  • Managed to clear several rejected shipments.

Acting Head, Drug Informatics Administration

Saudi Food and Drug Authority - SFDA
01.2012 - 01.2013
  • Established and headed the “Drug Informatics Administration” team of 4 members.
  • Continued to work on the harmonisation projects (ICH) in collaboration with EU advisors.
  • Involved and managed projects related to drug application structure and its internal workflow.
  • Member of the evaluation standards committee.
  • Supervised the electronic systems, which are related to submission and evaluation.
  • Collaborated in the building and designing of multiple regulatory software.
  • Provided several training sessions to the industry and SFDA employees.

Chief Pharmacist, Regulatory Affairs Department

Saudi Food and Drug Authority - SFDA
01.2010 - 01.2013
  • Regulatory revision of over 70 drug applications.
  • Supervised a team of RA admins who were responsible for dossier validation.
  • Contributor to several regulatory guidelines.
  • Liaison with international and local gov bodies.
  • Trainer for staff and industry.
  • Manager of one of the Drug Sector strategic projects.

Regulatory Pharmacist

Saudi Food and Drug Authority - SFDA
01.2005 - 01.2007
  • Secretary, Drug Sector Advisory Committee.
  • Secretary, Pharmaceuticals Patent Committee.
  • Rapporteur, Member, Drug Sector Website Committee.
  • Member of the research team for “Counterfeit Drugs.”

Education

BSc - Pharmaceutical Sciences

King Saud University
01.2005

MSc - Biomedical Informatics

Nova Southeastern University
01.2010

Skills

  • Regulatory Affairs
  • Pharmacovigilance
  • Project Management
  • Leadership
  • Soft Skills

Languages

Arabic
English

Personal Information

Nationality: Saudi Arabia

Work Availability

monday
tuesday
wednesday
thursday
friday
saturday
sunday
morning
afternoon
evening
swipe to browse

Timeline

Principal Consultant, Regulatory Affairs. Founder

PharmaKnowl Consulting
12.2019 - Current

Pharmacovigilance Manager

Aspen Pharmacare
01.2016 - 12.2019

Scientific Office and Regulatory Affairs Manager

Aspen Pharmacare
12.2013 - 12.2019

Acting Head, Drug Informatics Administration

Saudi Food and Drug Authority - SFDA
01.2012 - 01.2013

Chief Pharmacist, Regulatory Affairs Department

Saudi Food and Drug Authority - SFDA
01.2010 - 01.2013

Regulatory Pharmacist

Saudi Food and Drug Authority - SFDA
01.2005 - 01.2007

BSc - Pharmaceutical Sciences

King Saud University

MSc - Biomedical Informatics

Nova Southeastern University
Mohammed JobranRegulatory Affairs Consultant, SFDA.